About Temple University Cancer Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Temple University
3
INSYS Therapeutics Inc
2
Clinical Trials at Temple University Cancer Center
During the past decade, Temple University Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy Followed by Bone Marrow or Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Germ Cell Tumors
1990-11-01
2001-09-01
Completed
High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Poor-Prognosis Breast Cancer
1991-11-01
2003-12-01
Completed
Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma
1992-04-01
2001-06-01
Completed
High-Dose Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer
1997-09-01
2003-01-01
Completed
61
Study to Determine Maximum Tolerated Dose of LErafAON Combined With Radiotherapy in Patients With Advanced Malignancies
2001-03-01
2004-12-01
Completed
25
Study to Determine the Maximum Tolerated Dose of LErafAON in Patients With Advanced Solid Tumors
2001-03-01
2004-10-01
Completed
30
PANVAC™-VF Vaccine for the Treatment of Metastatic Pancreatic Cancer After Failing a Gemcitabine-Containing Regimen
2004-06-01
Unknown status
250
LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based Chemotherapy
2012-03-05
2017-12-27
Completed
795
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Temple University Cancer Center" #1 sponsor was "Temple University" with 3 trials, followed by "INSYS Therapeutics Inc" with 2 trials
sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Therion Biologics Corporation" with 1 trials sponsored and "UNC Lineberger Comprehensive Cancer Center"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Temple University Cancer Center"
#1 collaborator was "Fox Chase Cancer Center" with 3 trials as a collaborator, "Georgetown University" with 2 trials as a collaborator and "National Cancer Institute (NCI)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Temple University Cancer Center
According to Clinical.Site data, the most researched conditions in "Temple University Cancer Center" are
"Breast Cancer" (2 trials), "Neoplasms" (2 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Extragonadal Germ Cell Tumor" (1 trials) and "Lymphoma" (1 trials). Many other conditions were trialed in "Temple University Cancer Center" in a lesser frequency.
Clinical Trials Intervention Types at Temple University Cancer Center
Most popular intervention types in "Temple University Cancer Center" are "Drug" (7 trials), "Biological" (4 trials), "Procedure" (4 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "peripheral blood stem cell transplantation" (4 trials), "carboplatin" (3 trials), "cyclophosphamide" (3 trials), "etoposide" (3 trials) and "filgrastim" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Temple University Cancer Center
The vast majority of trials in "Temple University Cancer Center" are
7 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Temple University Cancer Center
Currently, there are NaN active trials in "Temple University Cancer Center".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Temple University Cancer Center,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Temple University Cancer Center, 5 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".